Cognitive and Self-regulatory Mechanisms of Obesity Study (COSMOS): Study protocol for a randomized controlled weight loss trial examining change in biomarkers, cognition, and self-regulation across two behavioral treatments

M. A.W. Hawkins, Janna Colaizzi, John Gunstad, Joel W. Hughes, Larry L. Mullins, Nancy Betts, Caitlin E. Smith, Natalie G. Keirns, Kathleen D. Vohs, Shirley M. Moore, Evan M. Forman, William R. Lovallo

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Obesity is a global epidemic, yet successful interventions are rare. Up to 60% of people fail to achieve clinically meaningful, short-term weight loss (5–10% of start weight), whereas up to 72% are unsuccessful at achieving long-term weight loss (5–10% loss for ≥ 5 years). Understanding how biological, cognitive, and self-regulatory factors work together to promote or to impede weight loss is clearly needed to optimize obesity treatment. This paper describes the methodology of the Cognitive and Self-regulatory Mechanisms of Obesity Study (the COSMOS trial). COSMOS is the first randomized controlled trial to investigate how changes in multiple biopsychosocial and cognitive factors relate to weight loss and one another across two weight loss treatments. The specific aims are to: 1) Confirm that baseline obesity-related physiological dysregulation is linked to cognitive deficits and poorer self-regulation, 2) Evaluate pre- to post-treatment change across time to assess individual differences in biomarkers, cognition, and self-regulation, and 3) Evaluate whether the acceptance-based treatment (ABT) group has greater improvements in outcomes (e.g., greater weight loss and less weight regain, improvements in biomarkers, cognition, and self-regulation), than the standard behavioral treatment group (SBT) from pre- to post-treatment and 1-year follow-up. The results of COSMOS will provide critical information about how dysregulation in biomarkers, cognition, and/or self-regulation is related to weight loss and whether weight loss treatments are differentially associated with these factors. This information will be used to identify promising treatment targets that are informed by biological, cognitive, and self-regulatory factors in order to advance obesity treatment.

Original languageEnglish
Pages (from-to)20-27
Number of pages8
JournalContemporary Clinical Trials
Volume66
DOIs
StatePublished - 1 Mar 2018
Externally publishedYes

Fingerprint

Cognition
Weight Loss
Obesity
Biomarkers
Weights and Measures
Self-Control
Individuality
Randomized Controlled Trials

Cite this

Hawkins, M. A.W. ; Colaizzi, Janna ; Gunstad, John ; Hughes, Joel W. ; Mullins, Larry L. ; Betts, Nancy ; Smith, Caitlin E. ; Keirns, Natalie G. ; Vohs, Kathleen D. ; Moore, Shirley M. ; Forman, Evan M. ; Lovallo, William R. / Cognitive and Self-regulatory Mechanisms of Obesity Study (COSMOS) : Study protocol for a randomized controlled weight loss trial examining change in biomarkers, cognition, and self-regulation across two behavioral treatments. In: Contemporary Clinical Trials. 2018 ; Vol. 66. pp. 20-27.
@article{7ee679accc3445c09d75944f92186267,
title = "Cognitive and Self-regulatory Mechanisms of Obesity Study (COSMOS): Study protocol for a randomized controlled weight loss trial examining change in biomarkers, cognition, and self-regulation across two behavioral treatments",
abstract = "Obesity is a global epidemic, yet successful interventions are rare. Up to 60{\%} of people fail to achieve clinically meaningful, short-term weight loss (5–10{\%} of start weight), whereas up to 72{\%} are unsuccessful at achieving long-term weight loss (5–10{\%} loss for ≥ 5 years). Understanding how biological, cognitive, and self-regulatory factors work together to promote or to impede weight loss is clearly needed to optimize obesity treatment. This paper describes the methodology of the Cognitive and Self-regulatory Mechanisms of Obesity Study (the COSMOS trial). COSMOS is the first randomized controlled trial to investigate how changes in multiple biopsychosocial and cognitive factors relate to weight loss and one another across two weight loss treatments. The specific aims are to: 1) Confirm that baseline obesity-related physiological dysregulation is linked to cognitive deficits and poorer self-regulation, 2) Evaluate pre- to post-treatment change across time to assess individual differences in biomarkers, cognition, and self-regulation, and 3) Evaluate whether the acceptance-based treatment (ABT) group has greater improvements in outcomes (e.g., greater weight loss and less weight regain, improvements in biomarkers, cognition, and self-regulation), than the standard behavioral treatment group (SBT) from pre- to post-treatment and 1-year follow-up. The results of COSMOS will provide critical information about how dysregulation in biomarkers, cognition, and/or self-regulation is related to weight loss and whether weight loss treatments are differentially associated with these factors. This information will be used to identify promising treatment targets that are informed by biological, cognitive, and self-regulatory factors in order to advance obesity treatment.",
author = "Hawkins, {M. A.W.} and Janna Colaizzi and John Gunstad and Hughes, {Joel W.} and Mullins, {Larry L.} and Nancy Betts and Smith, {Caitlin E.} and Keirns, {Natalie G.} and Vohs, {Kathleen D.} and Moore, {Shirley M.} and Forman, {Evan M.} and Lovallo, {William R.}",
year = "2018",
month = "3",
day = "1",
doi = "10.1016/j.cct.2017.12.010",
language = "English",
volume = "66",
pages = "20--27",
journal = "Contemporary Clinical Trials",
issn = "1551-7144",
publisher = "Elsevier Inc.",

}

Cognitive and Self-regulatory Mechanisms of Obesity Study (COSMOS) : Study protocol for a randomized controlled weight loss trial examining change in biomarkers, cognition, and self-regulation across two behavioral treatments. / Hawkins, M. A.W.; Colaizzi, Janna; Gunstad, John; Hughes, Joel W.; Mullins, Larry L.; Betts, Nancy; Smith, Caitlin E.; Keirns, Natalie G.; Vohs, Kathleen D.; Moore, Shirley M.; Forman, Evan M.; Lovallo, William R.

In: Contemporary Clinical Trials, Vol. 66, 01.03.2018, p. 20-27.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Cognitive and Self-regulatory Mechanisms of Obesity Study (COSMOS)

T2 - Study protocol for a randomized controlled weight loss trial examining change in biomarkers, cognition, and self-regulation across two behavioral treatments

AU - Hawkins, M. A.W.

AU - Colaizzi, Janna

AU - Gunstad, John

AU - Hughes, Joel W.

AU - Mullins, Larry L.

AU - Betts, Nancy

AU - Smith, Caitlin E.

AU - Keirns, Natalie G.

AU - Vohs, Kathleen D.

AU - Moore, Shirley M.

AU - Forman, Evan M.

AU - Lovallo, William R.

PY - 2018/3/1

Y1 - 2018/3/1

N2 - Obesity is a global epidemic, yet successful interventions are rare. Up to 60% of people fail to achieve clinically meaningful, short-term weight loss (5–10% of start weight), whereas up to 72% are unsuccessful at achieving long-term weight loss (5–10% loss for ≥ 5 years). Understanding how biological, cognitive, and self-regulatory factors work together to promote or to impede weight loss is clearly needed to optimize obesity treatment. This paper describes the methodology of the Cognitive and Self-regulatory Mechanisms of Obesity Study (the COSMOS trial). COSMOS is the first randomized controlled trial to investigate how changes in multiple biopsychosocial and cognitive factors relate to weight loss and one another across two weight loss treatments. The specific aims are to: 1) Confirm that baseline obesity-related physiological dysregulation is linked to cognitive deficits and poorer self-regulation, 2) Evaluate pre- to post-treatment change across time to assess individual differences in biomarkers, cognition, and self-regulation, and 3) Evaluate whether the acceptance-based treatment (ABT) group has greater improvements in outcomes (e.g., greater weight loss and less weight regain, improvements in biomarkers, cognition, and self-regulation), than the standard behavioral treatment group (SBT) from pre- to post-treatment and 1-year follow-up. The results of COSMOS will provide critical information about how dysregulation in biomarkers, cognition, and/or self-regulation is related to weight loss and whether weight loss treatments are differentially associated with these factors. This information will be used to identify promising treatment targets that are informed by biological, cognitive, and self-regulatory factors in order to advance obesity treatment.

AB - Obesity is a global epidemic, yet successful interventions are rare. Up to 60% of people fail to achieve clinically meaningful, short-term weight loss (5–10% of start weight), whereas up to 72% are unsuccessful at achieving long-term weight loss (5–10% loss for ≥ 5 years). Understanding how biological, cognitive, and self-regulatory factors work together to promote or to impede weight loss is clearly needed to optimize obesity treatment. This paper describes the methodology of the Cognitive and Self-regulatory Mechanisms of Obesity Study (the COSMOS trial). COSMOS is the first randomized controlled trial to investigate how changes in multiple biopsychosocial and cognitive factors relate to weight loss and one another across two weight loss treatments. The specific aims are to: 1) Confirm that baseline obesity-related physiological dysregulation is linked to cognitive deficits and poorer self-regulation, 2) Evaluate pre- to post-treatment change across time to assess individual differences in biomarkers, cognition, and self-regulation, and 3) Evaluate whether the acceptance-based treatment (ABT) group has greater improvements in outcomes (e.g., greater weight loss and less weight regain, improvements in biomarkers, cognition, and self-regulation), than the standard behavioral treatment group (SBT) from pre- to post-treatment and 1-year follow-up. The results of COSMOS will provide critical information about how dysregulation in biomarkers, cognition, and/or self-regulation is related to weight loss and whether weight loss treatments are differentially associated with these factors. This information will be used to identify promising treatment targets that are informed by biological, cognitive, and self-regulatory factors in order to advance obesity treatment.

UR - http://www.scopus.com/inward/record.url?scp=85041465959&partnerID=8YFLogxK

U2 - 10.1016/j.cct.2017.12.010

DO - 10.1016/j.cct.2017.12.010

M3 - Article

C2 - 29274893

AN - SCOPUS:85041465959

VL - 66

SP - 20

EP - 27

JO - Contemporary Clinical Trials

JF - Contemporary Clinical Trials

SN - 1551-7144

ER -